106 related articles for article (PubMed ID: 8982721)
1. Evaluation in rat of RS-79948-197 as a potential PET ligand for central alpha 2-adrenoceptors.
Hume SP; Ashworth S; Lammertsma AA; Opacka-Juffry J; Law MP; McCarron JA; Clark RD; Nutt DJ; Pike VW
Eur J Pharmacol; 1996 Dec; 317(1):67-73. PubMed ID: 8982721
[TBL] [Abstract][Full Text] [Related]
2. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB
Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
[TBL] [Abstract][Full Text] [Related]
4. [Ethyl-3H]RS-79948-197 alpha2-adrenoceptor autoradiography validation in alpha2-adrenoceptor knockout mice.
Fagerholm V; Philipp M; Hein L; Scheinin M
Eur J Pharmacol; 2004 Aug; 497(3):301-9. PubMed ID: 15336948
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of [O-methyl-11C]RS-15385-197 as a positron emission tomography radioligand for central alpha2-adrenoceptors.
Hume SP; Hirani E; Opacka-Juffry J; Osman S; Myers R; Gunn RN; McCarron JA; Clark RD; Melichar J; Nutt DJ; Pike VW
Eur J Nucl Med; 2000 May; 27(5):475-84. PubMed ID: 10853800
[TBL] [Abstract][Full Text] [Related]
6. Structure-affinity relationships of 12-sulfonyl derivatives of 5,8,8a,9,10,11,12,12a,13,13a-decahydro-6H-isoquino[2,1-g][1 ,6] naphthyridines at alpha-adrenoceptors.
Clark RD; Repke DB; Berger J; Nelson JT; Kilpatrick AT; Brown CM; MacKinnon AC; Clague RU; Spedding M
J Med Chem; 1991 Feb; 34(2):705-17. PubMed ID: 1671705
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological studies of 8-OH-DPAT-induced pupillary dilation in anesthetized rats.
Yu Y; Ramage AG; Koss MC
Eur J Pharmacol; 2004 Apr; 489(3):207-13. PubMed ID: 15087245
[TBL] [Abstract][Full Text] [Related]
9. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
Zonnenchein R; Diamant S; Atlas D
Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
[TBL] [Abstract][Full Text] [Related]
10. [3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors.
MacKinnon AC; Redfern WS; Brown CM
Br J Pharmacol; 1995 Sep; 116(2):1729-36. PubMed ID: 8528552
[TBL] [Abstract][Full Text] [Related]
11. [3H]p-aminoclonidine and [3H]idazoxan label different populations of imidazoline sites on rat kidney.
MacKinnon AC; Stewart M; Olverman HJ; Spedding M; Brown CM
Eur J Pharmacol; 1993 Feb; 232(1):79-87. PubMed ID: 8096190
[TBL] [Abstract][Full Text] [Related]
12. The alpha(1A)-adrenoceptor subtype mediates contraction in rat femoral resistance arteries.
Jarajapu YP; Hillier C; MacDonald A
Eur J Pharmacol; 2001 Jun; 422(1-3):127-35. PubMed ID: 11430923
[TBL] [Abstract][Full Text] [Related]
13. Quantitative autoradiographic localization in rat brain of alpha 2-adrenergic and non-adrenergic I-receptor binding sites labelled by [3H]rilmenidine.
King PR; Gundlach AL; Louis WJ
Brain Res; 1995 Mar; 675(1-2):264-78. PubMed ID: 7796138
[TBL] [Abstract][Full Text] [Related]
14. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
15. Receptor binding and functional evidence suggest that postsynaptic alpha 2-adrenoceptors in rat brain are of the alpha 2D subtype.
Heal DJ; Cheetham SC; Butler SA; Gosden J; Prow MR; Buckett WR
Eur J Pharmacol; 1995 Apr; 277(2-3):215-21. PubMed ID: 7493611
[TBL] [Abstract][Full Text] [Related]
16. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
18. RX 821002 as a tool for physiological investigation of alpha(2)-adrenoceptors.
Clarke RW; Harris J
CNS Drug Rev; 2002; 8(2):177-92. PubMed ID: 12177687
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
Wallace DR; Muskardin DT; Zahniser NR
Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
[TBL] [Abstract][Full Text] [Related]
20. [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine.
Uhlén S; Dambrova M; Näsman J; Schiöth HB; Gu Y; Wikberg-Matsson A; Wikberg JE
Eur J Pharmacol; 1998 Feb; 343(1):93-101. PubMed ID: 9551719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
